Valuation: Integra LifeSciences Holdings Corporation

Market Cap 143.07Cr 125.16Cr 115.41Cr 106.79Cr 202.69Cr 14TCr 206.08Cr 1.38TCr 541.81Cr 6.71TCr 537.09Cr 525.48Cr 23TCr P/E 2026 *
28.3x
P/E 2027 * 15.3x
Enterprise Value 276.9Cr 242.23Cr 223.38Cr 206.68Cr 392.29Cr 26TCr 398.85Cr 2.68TCr 1.05TCr 13TCr 1.04TCr 1.02TCr 45TCr EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.51x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+6.30%
1 week+1.88%
Current month+2.39%
1 month+2.74%
3 months+87.08%
6 months+35.42%
Current year+48.07%
1 week 17.01
Extreme 17.01
18.75
1 month 16.75
Extreme 16.75
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Free

Executive/Senior Manager

5,590 0.0072%
01/07Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+6.30%+1.88%+40.92%-54.29% 143.07Cr
-0.82%-1.05%-29.14%-11.24% 16TCr
+0.46%-0.96%-7.43%-4.07% 11TCr
-2.30%+2.01%+0.77%+58.47% 5.88TCr
+0.79%-3.68%+40.47%+55.85% 5.11TCr
+0.19%-4.57%-14.05%-41.29% 4.16TCr
+1.36%-5.42% - - 3.45TCr
-1.40%+2.48%-13.96%-42.37% 2.82TCr
+1.13%-2.21%+58.13%-3.75% 2.53TCr
-1.73%-3.06%-10.60%+1.91% 2.02TCr
Average +0.40%-0.60%+7.23%-4.53% 5.31TCr
Weighted average by Cap. -0.31%-0.71%-6.30%+1.96%

Financials

2026 *2027 *
Net sales 167.61Cr 146.62Cr 135.21Cr 125.1Cr 237.45Cr 16TCr 241.42Cr 1.62TCr 634.74Cr 7.86TCr 629.21Cr 615.6Cr 27TCr 173.01Cr 151.35Cr 139.57Cr 129.14Cr 245.11Cr 17TCr 249.2Cr 1.67TCr 655.21Cr 8.11TCr 649.5Cr 635.45Cr 28TCr
Net income 4.27Cr 3.74Cr 3.45Cr 3.19Cr 6.05Cr 407.89Cr 6.16Cr 41Cr 16Cr 200.3Cr 16Cr 16Cr 693.81Cr 7.46Cr 6.52Cr 6.02Cr 5.57Cr 11Cr 711.74Cr 11Cr 72Cr 28Cr 349.51Cr 28Cr 27Cr 1.21TCr
Net Debt 133.83Cr 117.08Cr 107.97Cr 100Cr 189.61Cr 13TCr 192.77Cr 1.29TCr 506.84Cr 6.27TCr 502.43Cr 491.56Cr 22TCr 117.59Cr 102.87Cr 95Cr 88Cr 166.6Cr 11TCr 169.38Cr 1.14TCr 445.34Cr 5.51TCr 441.46Cr 431.91Cr 19TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
09/26/09 $18.39 +6.30% 9,39,773
08/26/08 $17.30 -0.92% 7,02,386
07/26/07 $17.46 -3.96% 11,06,193
06/26/06 $18.18 +0.72% 8,82,014
02/26/02 $18.05 +0.89% 6,83,034
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.39USD
Average target price
18.00USD
Spread / Average Target
-2.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock